Back

Microvascular blood flow disturbances predict poor outcome of revascularization in CLTI patients

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Peripheral artery disease: endovascular and open treatments Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Assistant Professor Petra Korpisalo

Kuopio University Hospital, Kuopio (Finland)

7 More presentations in this session

Presentation thumbnail
Clinical impact of serum cholinesterase level on clinical outcomes in patients with lower extremity artery disease undergoing endovascular treatment
Doctor H. Shimono (Kagoshima, JP)
Abstract Slides Video
Presentation thumbnail
Patient and procedural characteristics of successful endovascular procedures in the BEST-CLI Trial and their relationship to major adverse limb events
Associate Professor S. Kinlay (Boston, US)
Abstract Slides Video
Presentation thumbnail
Impact of the lower extremity arterial calcification score on clinical outcomes after drug-coated balloon angioplasty for de novo femoropopliteal artery disease
Doctor K. Kawamura (Okayama, JP)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of low-dose versus high-dose paclitaxel-coated balloons in patients with femoropopliteal lesions: an updated and meta-analysis.
Doctor M. Desouki (Minneapolis, US)
Abstract Slides Video
Presentation thumbnail
Preclinical assessment of transcatheter-delivered expandable endoluminal polymeric graft fabricated by electrospinning of microfiber
Doctor K. Miyashita (Galway, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Peripheral artery disease: endovascular and open treatments

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Cutting-edge approaches to chronic limb threatening ischaemia
thumbnail
Congress Presentation
Patient and procedural characteristics of successful endovascular procedures in the BEST-CLI Trial and their relationship to major adverse limb events
thumbnail
Congress Presentation
Endogen microvascular dysfunction is associated with worse outcomes in heart transplantation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources